secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2026-06-03T13:04:18+00:00
Accession:  0001193125-26-254708
Event type: litigation
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome settles all SUNOSI patent litigation; generic entry deferred to 2040
---------------------------------------------------------------------------

- Resolved all outstanding SUNOSI patent litigation with the last first-to-file generic applicant.
- Settlement grants five companies right to sell generic SUNOSI starting September 1, 2040 (if pediatric exclusivity) or March 1, 2040.
- No other patent litigation remains for SUNOSI.
- Settlement will be submitted to FTC and DOJ for review as required by law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000119312526254708/0001193125-26-254708-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000119312526254708/axsm-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-254708

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer